C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/113 (2010.01) A61K 31/7088 (2006.01) A61K 31/7125 (2006.01) A61K 31/713 (2006.01) A61P 17/00 (2006.01) A61P 17/02 (2006.01) A61P 35/00 (2006.01) C07H 21/00 (2006.01)
Patent
CA 2733262
This invention provides compounds which comprise modified oligonucleotides capable of inhibitory expression of connective tissue growth factor and composition containing same as well as methods of treating hyperprolific disorders and fibrotic diseases, and of reducing scarring resulting from wound healing using such compounds.
La présente invention concerne des composés qui comprennent des oligonucléotides modifiés capables d'une expression inhibitrice du facteur de croissance des tissus conjonctifs et une composition contenant ces composés ainsi que les procédés de traitement de troubles hyperprolifératifs et de maladies fibreuses, et de réduction de cicatrice résultant d'une cicatrisation au moyen de ces composés.
Bennett C. Frank
Dean Nicholas M.
Foulkes J. Gordon
Freier Susan M.
O'donnell Niall
Benoit & Cote Associes Inc.
Excaliard Pharmaceuticals Inc.
Isis Pharmaceuticals Inc.
LandOfFree
Antisense oligonucleotides directed against connective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides directed against connective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides directed against connective... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1832931